scholarly article | Q13442814 |
P2093 | author name string | Francesco Pezzella | |
Omanma Adighibe | |||
P2860 | cites work | Real-time monitoring of actin polymerization in living cells using split luciferase. | Q52611124 |
JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues | Q58211219 | ||
The transcriptional program following p53 activation | Q73420921 | ||
Actin nucleation by a transcription co-factor that links cytoskeletal events with the p53 response | Q84012087 | ||
A novel cofactor for p300 that regulates the p53 response | Q22010639 | ||
Arginine methylation controls growth regulation by E2F-1 | Q24305116 | ||
p53-cofactor JMY is a multifunctional actin nucleation factor | Q24321681 | ||
Mdm2 targets the p53 transcription cofactor JMY for degradation | Q24337019 | ||
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain | Q27860534 | ||
Surfing the p53 network | Q28032484 | ||
Arginine methylation regulates the p53 response | Q28116284 | ||
A TPR motif cofactor contributes to p300 activity in the p53 response | Q28609764 | ||
A nucleator arms race: cellular control of actin assembly | Q29616146 | ||
DNA damage activates p53 through a phosphorylation-acetylation cascade | Q29616294 | ||
DNA damage signals through differentially modified E2F1 molecules to induce apoptosis | Q34241750 | ||
Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. | Q34393383 | ||
The p53 proto-oncogene can act as a suppressor of transformation | Q34440370 | ||
E2F1 pathways to apoptosis | Q34922303 | ||
The actin nucleation factor JMY is a negative regulator of neuritogenesis | Q35579811 | ||
Actin binding to WH2 domains regulates nuclear import of the multifunctional actin regulator JMY. | Q35790908 | ||
Disassembling adherens junctions: breaking up is hard to do. | Q36010869 | ||
The p53 response: emerging levels of co-factor complexity. | Q36113137 | ||
Control of cell migration: a tumour suppressor function for p53? | Q36397275 | ||
Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. | Q36710840 | ||
Mdm2 widens its repertoire. | Q36766371 | ||
Cadherins and cancer: how does cadherin dysfunction promote tumor progression? | Q37333596 | ||
A transcription co-factor integrates cell adhesion and motility with the p53 response. | Q37446442 | ||
Nucleating actin for invasion | Q37843451 | ||
Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases | Q39703803 | ||
Jasplakinolide: an actin-specific reagent that promotes actin polymerization | Q39797084 | ||
A new effector pathway links ATM kinase with the DNA damage response | Q40510958 | ||
JimMY on the stage: Linking DNA damage with cell adhesion and motility. | Q41886813 | ||
Out of the jaws of death: PRMT5 steers p53. | Q41949627 | ||
Double JMY: making actin fast | Q42558037 | ||
Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α. | Q43904364 | ||
Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression | Q46709821 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P577 | publication date | 2018-05-31 | |
P1433 | published in | Cancers | Q27722963 |
P1476 | title | The Role of JMY in p53 Regulation. | |
P478 | volume | 10 |
Search more.